Evidence map›Paper›PMID 29247238›Full record

ArticleScientific reports2017

TRPV1-mediated Pharmacological Hypothermia Promotes Improved Functional Recovery Following Ischemic Stroke.

Zhijuan Cao, Adithya Balasubramanian, Steen E Pedersen, Jonathan Romero, Robia G Pautler, Sean P Marrelli

Abstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. TRP Channels in Stroke.Neuroscience bulletin · 2024
    Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zhijuan CaoDepartment of Molecular Physiology and Biophysics-Cardiovascular Sciences Track, Baylor College of Medicine, Houston, TX, 77030, USA.
Adithya BalasubramanianDepartment of Anesthesiology, Baylor College of Medicine, Houston, TX, 77030, USA.
Steen E PedersenDepartment of Molecular Physiology and Biophysics-Cardiovascular Sciences Track, Baylor College of Medicine, Houston, TX, 77030, USA.
Jonathan RomeroDepartment of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, TX, 77030, USA.
Robia G PautlerDepartment of Molecular Physiology and Biophysics-Cardiovascular Sciences Track, Baylor College of Medicine, Houston, TX, 77030, USA.
Sean P MarrelliDepartment of Neurology, McGovern Medical School at UTHealth, Houston, TX, 77030, USA. Sean.P.Marrelli@uth.tmc.edu.

Funding

Role of vimentin in thrombosis and strokeR01NS094280 · NINDS · BAYLOR COLLEGE OF MEDICINE · PI CRUZ, MIGUEL ANGEL, MARRELLI, SEAN P · 2016 to 2020
$2.2M
Multiple mechanisms of TRPV1-mediated brain protection following strokeR01NS096186 · NINDS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MARRELLI, SEAN P · 2017 to 2020
$1.4M
TRPV1-mediated induction of a protective heat shock response after strokeR21NS090129 · NINDS · BAYLOR COLLEGE OF MEDICINE · PI MARRELLI, SEAN P · 2014 to 2015
$435k
Targeting thermoreceptors for therapeutic hypothermiaR21NS077413 · NINDS · BAYLOR COLLEGE OF MEDICINE · PI MARRELLI, SEAN P · 2011 to 2012
$430k
NINDS NIH HHS R01 NS094280NINDS NIH HHS R01 NS096186NINDS NIH HHS R21 NS077413NINDS NIH HHS R21 NS090129
6 · The paper itself

Abstract

Hypothermia shows promise for stroke neuroprotection, but current cooling strategies cause undesirable side effects that limit their clinical applications. Increasing efforts have focused on pharmacological hypothermia as a treatment option for stroke. Previously, we showed that activation of a thermoregulatory ion channel, transient receptor potential vanilloid 1 (TRPV1), by dihydrocapsaicin (DHC) produces reliable hypothermia. In this study, we investigate the effects of TRPV1-mediated hypothermia by DHC on long-term ischemic stroke injury and functional outcome. Hypothermia initiated at 3.5 hours after stroke significantly reduced primary cortical injury. Interestingly, hypothermia by DHC also significantly reduced secondary thalamic injury, as DHC-treated stroke mice exhibited 53% smaller thalamic lesion size. DHC-treated stroke mice further demonstrated decreased neuronal loss and astrogliosis in the thalamus and less thalamic fiber loss by diffusion tensor imaging (DTI). Importantly, a single 8 hour treatment of hypothermia by DHC after stroke provided long-term improvement in functional outcome, as DHC-treated mice exhibited improved behavioral recovery at one month post-stroke. These findings indicate that TRPV1-mediated hypothermia is effective in reducing both primary cortical injury and remote secondary thalamic injury, and a single treatment can produce persistent effects on functional recovery. These data highlight the therapeutic potential for TRPV1 agonism for stroke treatment.

Indexed as

AnimalsBrain IschemiaCapsaicinDiffusion Tensor ImagingDisease Models, AnimalHypothermiaMaleMiceMice, Inbred C57BLNeuroprotective AgentsRecovery of FunctionStrokeTRPV Cation ChannelsCapsaicindihydrocapsaicinNeuroprotective AgentsTRPV1 protein, mouseTRPV Cation Channels

Identifiers

PMID29247238
PMCPMC5732157

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.